332 related articles for article (PubMed ID: 9314550)
1. Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2.
Ishikawa H; Carrasco D; Claudio E; Ryseck RP; Bravo R
J Exp Med; 1997 Oct; 186(7):999-1014. PubMed ID: 9314550
[TBL] [Abstract][Full Text] [Related]
2. p100, a precursor of NF-κB2, inhibits c-Rel and reduces the expression of IL-23 in dendritic cells.
Mise-Omata S; Obata Y; Doi TS
Biochem Biophys Res Commun; 2014 Oct; 453(3):332-7. PubMed ID: 25305492
[TBL] [Abstract][Full Text] [Related]
3. Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein.
Carrasco D; Cheng J; Lewin A; Warr G; Yang H; Rizzo C; Rosas F; Snapper C; Bravo R
J Exp Med; 1998 Apr; 187(7):973-84. PubMed ID: 9529314
[TBL] [Abstract][Full Text] [Related]
4. CD40 regulates the processing of NF-kappaB2 p100 to p52.
Coope HJ; Atkinson PG; Huhse B; Belich M; Janzen J; Holman MJ; Klaus GG; Johnston LH; Ley SC
EMBO J; 2002 Oct; 21(20):5375-85. PubMed ID: 12374738
[TBL] [Abstract][Full Text] [Related]
5. The generation of nfkb2 p52: mechanism and efficiency.
Heusch M; Lin L; Geleziunas R; Greene WC
Oncogene; 1999 Nov; 18(46):6201-8. PubMed ID: 10597218
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of TCR signaling by NF-kappaB2/p100.
Legarda-Addison D; Ting AT
J Immunol; 2007 Jun; 178(12):7767-78. PubMed ID: 17548614
[TBL] [Abstract][Full Text] [Related]
7. The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis.
Novack DV; Yin L; Hagen-Stapleton A; Schreiber RD; Goeddel DV; Ross FP; Teitelbaum SL
J Exp Med; 2003 Sep; 198(5):771-81. PubMed ID: 12939342
[TBL] [Abstract][Full Text] [Related]
8. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.
Scheinman RI; Beg AA; Baldwin AS
Mol Cell Biol; 1993 Oct; 13(10):6089-101. PubMed ID: 8413211
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins.
Su F; Schneider RJ
J Virol; 1996 Jul; 70(7):4558-66. PubMed ID: 8676482
[TBL] [Abstract][Full Text] [Related]
10. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors.
Naumann M; Nieters A; Hatada EN; Scheidereit C
Oncogene; 1993 Aug; 8(8):2275-81. PubMed ID: 8336950
[TBL] [Abstract][Full Text] [Related]
11. Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs.
Sun SC; Ganchi PA; Béraud C; Ballard DW; Greene WC
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1346-50. PubMed ID: 8108414
[TBL] [Abstract][Full Text] [Related]
12. Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50.
Ishikawa H; Claudio E; Dambach D; Raventós-Suárez C; Ryan C; Bravo R
J Exp Med; 1998 Apr; 187(7):985-96. PubMed ID: 9529315
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
[TBL] [Abstract][Full Text] [Related]
14. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF.
Yilmaz ZB; Weih DS; Sivakumar V; Weih F
EMBO J; 2003 Jan; 22(1):121-30. PubMed ID: 12505990
[TBL] [Abstract][Full Text] [Related]
15. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism.
Mordmüller B; Krappmann D; Esen M; Wegener E; Scheidereit C
EMBO Rep; 2003 Jan; 4(1):82-7. PubMed ID: 12524526
[TBL] [Abstract][Full Text] [Related]
16. Role for protein kinase Ctheta (PKCtheta) in TCR/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-kappaB activation.
Li Y; Sedwick CE; Hu J; Altman A
J Biol Chem; 2005 Jan; 280(2):1217-23. PubMed ID: 15536066
[TBL] [Abstract][Full Text] [Related]
17. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.
Lanoix J; Lacoste J; Pepin N; Rice N; Hiscott J
Oncogene; 1994 Mar; 9(3):841-52. PubMed ID: 8108127
[TBL] [Abstract][Full Text] [Related]
18. The Nfkb1 and Nfkb2 proteins p105 and p100 function as the core of high-molecular-weight heterogeneous complexes.
Savinova OV; Hoffmann A; Ghosh G
Mol Cell; 2009 Jun; 34(5):591-602. PubMed ID: 19524538
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in aly/aly mice.
Seo Y; Fukushima H; Maruyama T; Kuroishi KN; Osawa K; Nagano K; Aoki K; Weih F; Doi T; Zhang M; Ohya K; Katagiri T; Hosokawa R; Jimi E
Mol Endocrinol; 2012 Mar; 26(3):414-22. PubMed ID: 22282470
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100.
Dobrzanski P; Ryseck RP; Bravo R
Oncogene; 1995 Mar; 10(5):1003-7. PubMed ID: 7898917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
